TGF‐β signalling and liver disease

I Fabregat, J Moreno‐Càceres, A Sánchez… - The FEBS …, 2016 - Wiley Online Library
The transforming growth factor‐beta (TGF‐β) family signalling pathways play essential roles
in the regulation of different cellular processes, including proliferation, differentiation …

Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy

M Tahmasebi Birgani, V Carloni - International journal of molecular …, 2017 - mdpi.com
Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the
human population. Different etiological factors such as hepatitis B and C virus, alcohol and …

TGF-β as multifaceted orchestrator in HCC progression: signaling, EMT, immune microenvironment, and novel therapeutic perspectives

F Dituri, S Mancarella, A Cigliano… - Seminars in liver …, 2019 - thieme-connect.com
Therapeutic attempts to treat hepatocellular carcinoma (HCC) frequently result in a poor
response or treatment failure. The efficacy of approved drugs and survival expectancies is …

SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis

J Li, M Li, T Wang, X Liu, X Zhu, Y Dai, K Zhai… - British journal of …, 2021 - nature.com
Background Many molecular alterations are shared by embryonic liver development and
hepatocellular carcinoma (HCC). Identifying the common molecular events would provide a …

Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer

H Nesbitt, Y Sheng, S Kamila, K Logan… - Journal of controlled …, 2018 - Elsevier
Pancreatic cancer remains one of the most lethal forms of cancer with a 10-year survival of<
1%. With little improvement in survival rates observed in the past 40 years, there is a …

[HTML][HTML] MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4

D Cheng, S Zhao, H Tang, D Zhang, H Sun, F Yu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background Tumor metastasis is one of the leading causes of poor prognosis for colorectal
cancer (CRC) patients. Loss of Smad4 contributes to aggression process in many human …

[HTML][HTML] Beyond cancer cells: How the tumor microenvironment drives cancer progression

H Sabit, B Arneth, S Abdel-Ghany, EF Madyan… - Cells, 2024 - mdpi.com
Liver cancer represents a substantial global health challenge, contributing significantly to
worldwide morbidity and mortality. It has long been understood that tumors are not …

Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis

MZ Wu, Y Yuan, BY Huang, JX Chen, BK Li… - … and Targeted Therapy, 2021 - nature.com
Aberrant activation of the TGF-β/SMAD signaling pathway is often observed in
hepatocellular carcinoma (HCC). Whether lncRNA regulates the TGF-β/SMAD signaling …

Mechanisms of action of bone morphogenetic proteins in cancer

H Davis, E Raja, K Miyazono, Y Tsubakihara… - Cytokine & growth factor …, 2016 - Elsevier
The bone morphogenetic proteins (BMPs) play fundamental roles in embryonic
development and control differentiation of a diverse set of cell types. It is therefore of no …

Hepatic stellate cells–from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology

RT Sufleţel, CS Melincovici, BA Gheban… - … of Morphology and …, 2021 - pmc.ncbi.nlm.nih.gov
Hepatic stellate cell (HSC), initially analyzed by von Kupffer, in 1876, revealed to be an
extraordinary mesenchymal cell, essential for both hepatocellular function and lesions …